Background: The aim of this study was to evaluate the usefulness of di
fferent markers to diagnose advanced infection by the human immunodefi
ciency virus (VIH) (AIDS or CD4 lymphocyte < 0.2 x 10(9)/L), establish
the degree of correlation and define markers of advanced infection in
primary health care. Methods: Clinical, hematological, biochemical, c
ellular, serological and immunological variables were analyzed in 146
patients diagnosed for the first time with HIV infection. The patients
were classified into three stages: A (II, III, CDC-1987), B (IV-A, IV
-C2) and C or advanced (IV-C1, IV-D). The following data were compared
: the results in the three stages, the degree of correlation, the spec
ificity and sensitivity to the diagnosis of AIDS. Two multiple logisti
c regression models were established: the first for all the variables
and the second for only those available in primary health care. Result
s: All the markes except the triglycerides, IgG, IgM, and beta2-microg
lobulin presented significant differences in the stages (p < 0.05). Wi
th the exception of the CD3+, CD4+ and CD8+ lymphocytes (r greater-tha
n-or-equal-to 0.6 or -0.6) the remaining variables were independent. T
he decrease in CD4+ and the increase in neopterine were very sensitive
markers (> 95%) but only hyperamylasemia demonstrated a specificity g
reater than 95% for the diagnosis of advanced infection. Oropharyngeal
candidiasis (OR =4.80) and the CD4+ lymphocyte (OR = 0.99) had the gr
eatest weight in the first model. In the second model the most signifi
cant markers were weight loss (OR = 4.41), a decrease in lymphocytes (
OR = 7.65) and an increase in IgA (OR = 5.82) with p < 0.01 and a pred
ictive value of 85.16%. Conclusions: The presence of weight loss, lymp
hocyte count < 1 x 10(9)/L and an increase in IgA may be used in prima
ry health care to diagnose advanced infection by the human immunodefic
iency virus. Asymptomatic hyperamylasemia with no apparent cause sugge
sts advanced infection.